Lepu Medical Technology (Beijing) Co., Ltd.
20
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 20 trials
100.0%
+13.5% vs industry average
15%
3 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer
Role: collaborator
Pembrolizumab + MRGOO3 as Neoadjuvant in NPC
Role: collaborator
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
Role: collaborator
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck
Role: collaborator
MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma
Role: collaborator
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
Role: lead
To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose Measurement
Role: lead
Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease
Role: lead
Treatment of Urethral Stricture With Urethral Drug Ball
Role: lead
Ultrasound Ablation for Essential Hypertension（FIM）
Role: lead
Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater
Role: lead
Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement System
Role: lead
Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions
Role: lead
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Role: lead
A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease
Role: lead
NeoVas Bioresorbable Coronary Scaffold Registry Study
Role: lead
NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial
Role: lead
NeoVas Bioresorbable Coronary Scaffold First-in-Man Study
Role: lead
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study
Role: lead
LEPU Renal Denervation System for Resistant Hypertension
Role: lead
All 20 trials loaded